Aptevo Therapeutics Inc - ESG Rating & Company Profile powered by AI
This analysis of Aptevo Therapeutics Inc was assembled by All Street Sevva using proprietary Cognitive Robots. This page displays a free Sustainability report covering Aptevo Therapeutics Inc. Other corporations in the rating industry group for Aptevo Therapeutics Inc are shownin the table.
Aptevo Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 2.7, social score of 0.0 and governance score of 2.0.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Aptevo Therapeutics Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aptevo Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aptevo Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Aptevo Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aptevo Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Aptevo Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aptevo Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aptevo Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Aptevo Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aptevo Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aptevo Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aptevo Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aptevo Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aptevo Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aptevo Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Aptevo Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Aptevo Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aptevo Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aptevo Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.